Impact of the COVID-19 Pandemic on Cancer Clinical Trials
In this episode of Speaking of SurgOnc®, Rick Greene, MD, and Judy Boughey, MD, discuss the impact of COVID-19 on US clinical research at the local, c...
Speaking of SurgOnc
Share:
Listens: 22
About
"Speaking of SurgOnc" is a podcast series brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology(SSO). Dr. Frederick L. (Rick) Greene, ASO Deputy Editor, will explore and expand upon ideas and concepts described in articles published in the Annals of Surgical Oncology. Dr. Greene will interview authors and leading experts about topics of current importance in surgical oncology.
Adherence to NCCN Guidelines for Genetic Testing in Breast Cancer Patients: Who Are We Missing?
Rick Greene, MD, and Elisa Port, MD, discuss surgeon adherence to NCCN guidelines and patterns of testing in newly diagnosed breast cancer patients. D...
Completion Thyroidectomy is Less Common Following Updated 2015 American Thyroid Association Guidelines
Rick Greene, MD and Nancy Cho, MD discuss the impact of the 2015 American Thyroid Association guideline change on clinical practice in low-risk differ...
Race and Gender Disparities in Access to Parathyroidectomy: A Need to Change Processes for Diagnosis and Referral to Surgeons
Rick Greene, MD, and Courtney Balentine, MD, discuss race and gender disparities in the time from initial diagnosis of hyperparathyroidism to treatmen...
Longitudinal Analysis of Quality-of-Life Recovery After Gastrectomy for Cancer
Rick Greene, MD and Vivian Strong, MD discuss factors associated with quality-of-life recovery after gastrectomy. Dr. Strong is author of “Longitudina...
Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma
Rick Greene, MD, and Melissa Hogg, MD, discuss the relationship of serum CA19-9 to other markers of response, and the related thresholds correlating t...
Surgical Oncologists and the COVID-19 Pandemic: Guiding Cancer Patients Effectively through Turbulence and Change
Rick Greene, MD, and Ken Tanabe, MD, discuss the need for surgical oncologists to remain focused on providing optimal care for our cancer patients whi...
Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade
Rick Greene, MD and Charlotte Ariyan, MD, PhD, discuss survival outcomes in patients with metastatic melanoma who were selected for surgery following ...
Opioid Consumption Following Breast Surgery Decreases with a Brief Educational Intervention: A Randomized, Controlled Trial
Rick Greene, MD and Katie Egan, MD discuss the use of an educational intervention to decrease opioid consumption among breast surgery patients. Dr. Eg...
The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cance
Rick Green, MD and Dr. Anna Weiss, MD discuss clinical trials that have defined the role of neoadjuvant endocrine therapy in patients with estrogen re...